Atlas Trials

A Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCM

Clinical trial NCT03723655 · COMPLETED

Trial details

NCT number
NCT03723655
Sponsor
Bristol-Myers Squibb
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Hypertrophic CardiomyopathyObstructive Hypertrophic CardiomyopathyNon-obstructive Hypertrophic Cardiomyopathy
Start date
2018-09-27
Primary completion
2026-01-16
Enrollment
314

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.